Insider Transactions
Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Jul 26, 2022 |
VP-General Counsel & Secretary
Trans History: 21
|
VP-General Counsel & Secretary | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 76,818 | -- | 389,647 |
Jul 26, 2022 |
VP-General Counsel & Secretary
Trans History: 21
|
VP-General Counsel & Secretary | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 51,750 | -- | 51,750 |
Jun 03, 2022 |
Director
Trans History: 11
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 27,353 | -- | 155,442 |
Jun 03, 2022 |
Director
Trans History: 121
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 27,353 | -- | 245,532 |
Jun 03, 2022 |
Director
Trans History: 4
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 27,353 | -- | 93,239 |
Jun 03, 2022 |
Director
Trans History: 115
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 27,353 | -- | 245,466 |
Jun 03, 2022 |
Director
Trans History: 126
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 27,353 | -- | 179,482 |
Aug 20, 2021 |
Director
Trans History: 11
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 65,886 | -- | 218,089 |
Aug 20, 2021 |
Director
Trans History: 11
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 65,885 | -- | 65,885 |
Aug 20, 2021 |
CCO & CIO
Trans History: 13
|
CCO & CIO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 392,175 | -- | 431,862 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.